Evidence map›Paper›PMID 28431282›Full record

ArticleVirology2017

The role of pharmacologic modulation of autophagy on anal cancer development in an HPV mouse model of carcinogenesis.

Brooks L Rademacher, Kristina A Matkowskyj, Louise M Meske, Alexis Romero, Hana Sleiman, Evie H Carchman

Abstract read
In one paragraph

Article in Virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Topical application of a dual PI3K/mTOR inhibitor prevents anal carcinogenesis in a human papillomavirus mouse model of anal cancer.European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) · 2019
    Article
  9. Article
  10. Human Papilloma Virus and Autophagy.International journal of molecular sciences · 2018
    Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Brooks L RademacherUniversity of Wisconsin, Department of Surgery, CSC K4/730, 600 Highland Avenue, Madison, WI 53792-7375, USA.
Kristina A MatkowskyjUniversity of Wisconsin, Department of Pathology and Laboratory Medicine, L5/183 CSC-MC 8550, 600 Highland Avenue, Madison, WI 53792-8550, USA.
Louise M MeskeUniversity of Wisconsin, Department of Surgery, CSC K4/730, 600 Highland Avenue, Madison, WI 53792-7375, USA.
Alexis RomeroUniversity of Wisconsin, Department of Surgery, CSC K4/730, 600 Highland Avenue, Madison, WI 53792-7375, USA.
Hana SleimanUniversity of Wisconsin, Department of Surgery, CSC K4/730, 600 Highland Avenue, Madison, WI 53792-7375, USA.
Evie H CarchmanUniversity of Wisconsin, Department of Surgery, CSC K4/730, 600 Highland Avenue, Madison, WI 53792-7375, USA. Electronic address: carchman@surgery.wisc.edu.
University of Wisconsin–Madison · US

Funding

UW Surgical Oncology Research Training Program (UW-SORT)T32CA090217 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI Muhammed Murtaza, Heather B Neuman · 2001 to 2026
$8.3M
NCI NIH HHS T32 CA090217
6 · The paper itself

Abstract

Autophagy is an intracellular, catabolic process that maintains cellular health. We examined the response of pharmacologic modulation of autophagy in an HPV mouse model of anal carcinogenesis. K14E6/E7 mice were treated with the topical carcinogen DMBA weekly and assessed for tumors over 20 weeks. Concurrently, they were given either chloroquine or BEZ235, to inhibit or induce autophagy, respectively. Time to tumor onset was examined. Immunofluorescence (IF) was performed for LC3β and p62 to examine autophagy. All DMBA treated K14E6/E7 mice developed anal cancer, contrary to zero of the no DMBA treated mice. Chloroquine plus DMBA resulted in a significant decrease in the time to tumor onset compared to K14E6/E7 treated with DMBA. Only 40% BEZ235 plus DMBA treated mice developed anal cancer. Autophagic induction with DMBA and BEZ235, and autophagic inhibition with chloroquine were confirmed via IF. Anal carcinogenesis can be inhibited or induced via pharmacologic modulation of autophagy.

Indexed as

AnimalsAntiviral AgentsAnus NeoplasmsAutophagyCarcinogenesisChloroquineDisease Models, AnimalHuman papillomavirus 16HumansMicePapillomavirus InfectionsAntiviral AgentsChloroquineAnal cancerAnal dysplasiaAutophagyBEZ235ChemopreventionHPV

Identifiers

PMID28431282
PMCPMC5584602
OpenAlexW2605617080

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.